$36.88 Billion in Sales Expected for Cardinal Health Inc (CAH) This Quarter

Equities research analysts predict that Cardinal Health Inc (NYSE:CAH) will report sales of $36.88 billion for the current fiscal quarter, Zacks Investment Research reports. Five analysts have issued estimates for Cardinal Health’s earnings, with the lowest sales estimate coming in at $36.26 billion and the highest estimate coming in at $37.30 billion. Cardinal Health reported sales of $35.35 billion in the same quarter last year, which would suggest a positive year over year growth rate of 4.3%. The company is expected to issue its next quarterly earnings results on Monday, August 5th.

According to Zacks, analysts expect that Cardinal Health will report full year sales of $145.15 billion for the current year, with estimates ranging from $144.00 billion to $146.06 billion. For the next financial year, analysts forecast that the firm will report sales of $151.41 billion, with estimates ranging from $148.24 billion to $153.29 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover Cardinal Health.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, May 9th. The company reported $1.59 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.43 by $0.16. The company had revenue of $35.23 billion during the quarter, compared to analyst estimates of $35.09 billion. The firm’s revenue for the quarter was up 4.7% compared to the same quarter last year. During the same quarter last year, the business earned $1.39 EPS.

A number of equities analysts have weighed in on CAH shares. Wolfe Research started coverage on shares of Cardinal Health in a report on Tuesday, April 2nd. They issued an “underperform” rating on the stock. ValuEngine upgraded shares of Cardinal Health from a “strong sell” rating to a “sell” rating in a report on Friday, February 8th. Zacks Investment Research lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a report on Tuesday, April 9th. Finally, Guggenheim started coverage on shares of Cardinal Health in a report on Wednesday, April 17th. They issued a “neutral” rating and a $51.00 price target on the stock. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the stock. Cardinal Health has a consensus rating of “Hold” and an average target price of $56.20.

Large investors have recently bought and sold shares of the stock. WP Advisors LLC acquired a new position in shares of Cardinal Health during the 1st quarter valued at $26,000. Bremer Bank National Association acquired a new position in shares of Cardinal Health during the 1st quarter valued at $27,000. Transamerica Financial Advisors Inc. acquired a new position in shares of Cardinal Health during the 4th quarter valued at $32,000. CNB Bank purchased a new stake in Cardinal Health during the 4th quarter worth $36,000. Finally, Farmers National Bank purchased a new stake in Cardinal Health during the 1st quarter worth $43,000. Institutional investors and hedge funds own 87.67% of the company’s stock.

Shares of CAH opened at $45.03 on Friday. The firm has a market capitalization of $13.42 billion, a price-to-earnings ratio of 8.69, a P/E/G ratio of 1.43 and a beta of 1.14. Cardinal Health has a fifty-two week low of $42.17 and a fifty-two week high of $58.31. The company has a current ratio of 1.07, a quick ratio of 0.54 and a debt-to-equity ratio of 1.22.

The firm also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Monday, July 1st will be issued a dividend of $0.4811 per share. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, June 28th. This represents a $1.92 annualized dividend and a dividend yield of 4.27%. Cardinal Health’s payout ratio is presently 38.20%.

About Cardinal Health

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

Read More: Why is the Consumer Price Index (CPI) important?

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.